Advertisement
Original Article| Volume 62, ISSUE 4, P314-320, August 15, 2007

Download started.

Ok

Depression and Inflammation in Patients With Coronary Heart Disease: Findings from the Heart and Soul Study

      Background

      Depression and inflammation independently predict adverse cardiovascular outcomes in patients with coronary heart disease (CHD). Depression has been associated with elevated levels of inflammation in otherwise healthy patients without known CHD. However, studies investigating the link between depression and inflammation in patients with established CHD have produced inconclusive results.

      Methods

      We sought to examine the association of major depression with inflammation in 984 outpatients with established CHD from the Heart and Soul Study. We assessed current major depression with the Computerized Diagnostic Interview Schedule and collected venous blood samples for measurement of five inflammatory biomarkers (white blood cell count, CD40 ligand, C-reactive protein [CRP], fibrinogen, and interleukin-6 [IL-6]). We used multivariate analysis of variance to examine the association of current depression with inflammatory markers, adjusted for potential confounding variables.

      Results

      Of the 984 participants, 217 (22%) had current major depression. Depression was not associated with increased levels of any inflammatory marker. Contrary to our hypothesis, depression was associated with lower levels of CRP (p = .09), fibrinogen (p = .006), and IL-6 (p = .007) in both unadjusted and adjusted models.

      Conclusions

      We found no evidence that current depression is associated with greater inflammation in outpatients with CHD. Inflammation is unlikely to explain the adverse cardiovascular outcomes associated with depression in patients with established CHD.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Albert M.A.
        • Danielson E.
        • Rifai N.
        • Ridker P.M.
        Effect of statin therapy on C-reactive protein levels: The pravastatin inflammation/CRP evaluation (PRINCE): A randomized trial and cohort study.
        JAMA. 2001; 286: 64-70
        • American Psychiatric Association
        Diagnostic and Statistical Manual of Mental Disorders. 4th ed. American Psychiatric Association, Washington, DC2000 (Text Revision)
        • Barth J.
        • Schumacher M.
        • Herrmann-Lingen C.
        Depression as a risk factor for mortality in patients with coronary heart disease: A meta-analysis.
        Psychosom Med. 2004; 66: 802-813
        • Beattie M.S.
        • Shlipak M.G.
        • Liu H.
        • Browner W.S.
        • Schiller N.B.
        • Whooley M.A.
        C-reactive protein and ischemia in users and nonusers of beta-blockers and statins: Data from the Heart and Soul Study.
        Circulation. 2003; 107: 245-250
        • Carney R.M.
        • Blumenthal J.A.
        • Stein P.K.
        • Watkins L.
        • Catellier D.
        • Berkman L.F.
        • et al.
        Depression, heart rate variability, and acute myocardial infarction.
        Circulation. 2001; 104: 2024-2028
        • Danner M.
        • Kasl S.V.
        • Abramson J.L.
        • Vaccarino V.
        Association between depression and elevated C-reactive protein.
        Psychosom Med. 2003; 65: 347-356
        • Dentino A.N.
        • Pieper C.F.
        • Rao M.K.
        • Currie M.S.
        • Harris T.
        • Blazer D.G.
        • Cohen H.J.
        Association of interleukin-6 and other biologic variables with depression in older people living in the community.
        J Am Geriatr Soc. 1999; 47: 6-11
      1. Dorland’s Illustrated Medical Dictionary. 30th ed. Saunders, Philadelphia2003
        • Empana J.P.
        • Sykes D.H.
        • Luc G.
        • Juhan-Vague I.
        • Arveiler D.
        • Ferrieres J.
        • et al.
        Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: The Prospective Epidemiological Study of Myocardial Infarction (PRIME).
        Circulation. 2005; 111: 2299-2305
        • Evans D.L.
        • Charney D.S.
        • Lewis L.
        • Golden R.N.
        • Gorman J.M.
        • Krishnan K.R.
        • et al.
        Mood disorders in the medically ill: Scientific review and recommendations.
        Biol Psychiatry. 2005; 58: 175-189
        • Folsom A.R.
        • Qamhieh H.T.
        • Flack J.M.
        • Hilner J.E.
        • Liu K.
        • Howard B.V.
        • Tracy R.P.
        Plasma fibrinogen: Levels and correlates in young adults.
        Am J Epidemiol. 1993; 138: 1023-1036
        • Ford D.E.
        • Erlinger T.P.
        Depression and C-reactive protein in US adults: Data from the Third National Health and Nutrition Examination Survey.
        Arch Intern Med. 2004; 164: 1010-1014
        • Gehi A.K.
        • Rumsfeld J.S.
        • Liu H.
        • Schiller N.B.
        • Whooley M.A.
        Relation of self-reported angina pectoris to inducible myocardial ischemia in patients with known coronary artery disease: The Heart and Soul Study.
        Am J Cardiol. 2003; 92: 705-707
        • Janszky I.
        • Lekander M.
        • Blom M.
        • Georgiades A.
        • Ahnve S.
        Self-rated health and vital exhaustion, but not depression, is related to inflammation in women with coronary heart disease.
        Brain Behav Immun. 2005; 19: 555-563
        • Kop W.J.
        • Gottdiener J.S.
        • Tangen C.M.
        • Fried L.P.
        • McBurnie M.A.
        • Walston J.
        • et al.
        Inflammation and coagulation factors in persons > 65 years of age with symptoms of depression but without evidence of myocardial ischemia.
        Am J Cardiol. 2002; 89: 419-424
        • Kroenke K.
        • Spitzer R.L.
        • Williams J.B.
        The PHQ-9 validity of a brief depression severity measure.
        J Gen Intern Med. 2001; 16: 606-613
        • Kuo H.K.
        • Yen C.J.
        • Chang C.H.
        • Kuo C.K.
        • Chen J.H.
        • Sorond F.
        Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: Systematic review and meta-analysis.
        Lancet Neurol. 2005; 4: 371-380
        • Ladwig K.H.
        • Marten-Mittag B.
        • Lowel H.
        • Doring A.
        • Koenig W.
        C-reactive protein, depressed mood, and the prediction of coronary heart disease in initially healthy men: Results from the MONICA-KORA Augsburg Cohort Study 1984–1998.
        Eur Heart J. 2005; 26: 2537-2542
        • Lahlou-Laforet K.
        • Alhenc-Gelas M.
        • Pornin M.
        • Bydlowski S.
        • Seigneur E.
        • Benetos A.
        • et al.
        Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
        Am J Cardiol. 2006; 97: 1287-1291
        • Lesperance F.
        • Frasure-Smith N.
        • Theroux P.
        • Irwin M.
        The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes.
        Am J Psychiatry. 2004; 161: 271-277
        • Lett H.S.
        • Blumenthal J.A.
        • Babyak M.A.
        • Sherwood A.
        • Strauman T.
        • Robins C.
        • Newman M.F.
        Depression as a risk factor for coronary artery disease: Evidence, mechanisms, and treatment.
        Psychosom Med. 2004; 66: 305-315
        • Lubbock L.A.
        • Goh A.
        • Ali S.
        • Ritchie J.
        • Whooley M.A.
        Relation of low socioeconomic status to C-reactive protein in patients with coronary heart disease (from the heart and soul study).
        Am J Cardiol. 2005; 96: 1506-1511
        • Maes M.
        • Bosmans E.
        • De Jongh R.
        • Kenis G.
        • Vandoolaeghe E.
        • Neels H.
        Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression.
        Cytokine. 1997; 9: 853-858
        • Margaglione M.
        • Grandone E.
        • Mancini F.P.
        • Di Minno G.
        Drugs affecting plasma fibrinogen levels.
        Prog Drug Res. 1996; 46: 169-181
        • Matthies K.M.
        • Newman J.L.
        • Hodzic A.
        • Wingett D.G.
        Differential regulation of soluble and membrane CD40L proteins in T cells.
        Cell Immunol. 2006; 241: 47-58
        • McAdams C.
        • Leonard B.E.
        Neutrophil and monocyte phagocytosis in depressed patients.
        Prog Neuropsychopharmacol Biol Psychiatry. 1993; 17: 971-984
        • McManus D.
        • Pipkin S.S.
        • Whooley M.A.
        Screening for depression in patients with coronary heart disease (data from the Heart and Soul Study).
        Am J Cardiol. 2005; 96: 1076-1081
        • Miller G.E.
        • Freedland K.E.
        • Duntley S.
        • Carney R.M.
        Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes.
        Am J Cardiol. 2005; 95: 317-321
        • Miller G.E.
        • Stetler C.A.
        • Carney R.M.
        • Freedland K.E.
        • Banks W.A.
        Clinical depression and inflammatory risk markers for coronary heart disease.
        Am J Cardiol. 2002; 90: 1279-1283
        • O’Toole M.T.
        Miller-Keane Encyclopedia & Dictionary of Medicine, Nursing, & Allied Health. 7th ed. Saunders, Philadelphia2003
        • Otte C.
        • Marmar C.R.
        • Pipkin S.S.
        • Moos R.
        • Browner W.S.
        • Whooley M.A.
        Depression and 24-hour urinary cortisol in medical outpatients with coronary heart disease: The Heart and Soul Study.
        Biol Psychiatry. 2004; 56: 241-247
        • Otte C.
        • Neylan T.C.
        • Pipkin S.
        • Browner W.S.
        • Whooley M.A.
        Depressive symptoms and 24-hour urinary norepinephrine excretion levels in patients with coronary disease: Findings from The Heart and Soul Study.
        Am J Psychiatry. 2005; 162: 2139-2145
        • Panagiotakos D.B.
        • Pitsavos C.
        • Chrysohoou C.
        • et al.
        Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study.
        Eur Heart J. 2004; 25: 492-499
        • Pearson T.A.
        • Mensah G.A.
        • Alexander R.W.
        • Anderson J.L.
        • Cannon 3rd, R.O.
        • Criqui M.
        • et al.
        Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.
        Circulation. 2003; 107: 499-511
        • Penninx B.W.
        • Kritchevsky S.B.
        • Yaffe K.
        • Newman A.B.
        • Simonsick E.M.
        • Rubin S.
        • et al.
        Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study.
        Biol Psychiatry. 2003; 54: 566-572
        • Raison C.L.
        • Capuron L.
        • Miller A.H.
        Cytokines sing the blues: Inflammation and the pathogenesis of depression.
        Trends Immunol. 2006; 27: 24-31
        • Ridker P.M.
        Clinical application of C-reactive protein for cardiovascular disease detection and prevention.
        Circulation. 2003; 107: 363-369
        • Robins L.
        • Helzer J.
        • Croughan J.
        • Ratcliff K.
        National Institute of Mental Health Diagnostic Interview Schedule: Its history, characteristics, and validity.
        Arch Gen Psychiatry. 1981; 38: 381-389
        • Rothermundt M.
        • Arolt V.
        • Peters M.
        • Gutbrodt H.
        • Fenker J.
        • Kersting A.
        • Kirchner H.
        Inflammatory markers in major depression and melancholia.
        J Affect Disord. 2001; 63: 93-102
        • Ruo B.
        • Rumsfeld J.S.
        • Hlatky M.A.
        • Liu H.
        • Browner W.S.
        • Whooley M.A.
        Depressive symptoms and health-related quality of life: The Heart and Soul Study.
        JAMA. 2003; 290: 215-221
        • Schins A.
        • Tulner D.
        • Lousberg R.
        • Kenis G.
        • Delanghe J.
        • Crijns H.J.
        • et al.
        Inflammatory markers in depressed post-myocardial infarction patients.
        J Psychiatr Res. 2005; 39: 137-144
        • Sluzewska A.
        • Rybakowski J.
        • Bosmans E.
        • Sobieska M.
        • Berghmans R.
        • Maes M.
        • Wiktorowicz K.
        Indicators of immune activation in major depression.
        Psychiatry Res. 1996; 64: 161-167
        • Spitzer R.L.
        • Kroenke K.
        • Williams J.B.
        Validation and utility of a self-report version of PRIME-MD: The PHQ primary care study.
        JAMA. 1999; 282: 1737-1744
        • Stewart R.A.
        • North F.M.
        • West T.M.
        • Sharples K.J.
        • Simes R.J.
        • Colquhoun D.M.
        • et al.
        Depression and cardiovascular morbidity and mortality: Cause or consequence?.
        Eur Heart J. 2003; 24: 2027-2037
        • Suarez E.C.
        C-reactive protein is associated with psychological risk factors of cardiovascular disease in apparently healthy adults.
        Psychosom Med. 2004; 66: 684-691
        • Tiemeier H.
        • Hofman A.
        • van Tuijl H.R.
        • Kiliaan A.J.
        • Meijer J.
        • Breteler M.M.
        Inflammatory proteins and depression in the elderly.
        Epidemiology. 2003; 14: 103-107
        • van Melle J.P.
        • de Jonge P.
        • Spijkerman T.A.
        • Tijssen J.G.
        • Ormel J.
        • van Veldhuisen D.J.
        • et al.
        Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: A meta-analysis.
        Psychosom Med. 2004; 66: 814-822
        • Wells K.B.
        • Hays R.D.
        • Burnam M.A.
        • Rogers W.
        • Greenfield S.
        • Ware Jr., J.
        Detection of depressive disorder for patients receiving prepaid or fee-for-service care.
        JAMA. 1989; 262: 3298-3302